Edition:
United States

IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

167.56USD
26 May 2017
Change (% chg)

$0.16 (+0.10%)
Prev Close
$167.40
Open
$166.97
Day's High
$167.98
Day's Low
$166.71
Volume
125,717
Avg. Vol
264,168
52-wk High
$171.98
52-wk Low
$85.98

Latest Key Developments (Source: Significant Developments)

Idexx Laboratories reports Q1 EPS $0.77
Friday, 28 Apr 2017 07:00am EDT 

April 28 (Reuters) - Idexx Laboratories Inc :Sees FY earnings per share of $2.95 to $3.11 .Idexx Laboratories announces first quarter results.Q1 earnings per share $0.77.Q1 revenue rose 11 percent to $462 million.Says increases 2017 eps outlook range by $0.10 to $2.95 - $3.11.Says raising its 2017 revenue outlook by $15 million to $1,925 million - $1,950 million.Idexx laboratories inc sees fy 2017 capital expenditures of about $90 million.Q1 earnings per share view $0.61, revenue view $454.9 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.94, revenue view $1.92 billion -- Thomson Reuters I/B/E/S.  Full Article

Idexx Laboratories reported Q2 EPS $0.74
Tuesday, 2 Aug 2016 07:00am EDT 

Idexx Laboratories Inc : Idexx Laboratories announces second quarter results . Q2 revenue rose 13 percent to $467 million . Q2 earnings per share $0.74 . Sees FY 2016 earnings per share $2.32 to $2.39 . Increasing its 2016 revenue guidance by $25 million and its 2016 EPS guidance by $0.14 per share . FY2016 earnings per share view $2.21, revenue view $1.74 billion -- Thomson Reuters I/B/E/S . Sees FY 2016 revenue $1,755 million to $1,775 million . Sees FY 2016 earnings per share $2.32 to $2.39 .Q2 earnings per share view $0.62, revenue view $444.8 million -- Thomson Reuters I/B/E/S.  Full Article

IDEXX Laboratories Inc updates FY 2015 EPS guidance; gives FY 2016 EPS guidance below analysts estimates
Wednesday, 28 Oct 2015 06:30am EDT 

IDEXX Laboratories Inc:Updates FY 2015 adjusted EPS guidance to $2.04-$2.07.Expects FY 2016 revenue in the range of $1.715-$1.735 bln.Expects FY 2016 EPS in the range of $2.09-$2.16.FY 2015 EPS of $2.10 - Thomson Reuters I/B/E/S.FY 2016 revenue of $1.72 bln and EPS of $2.31 - Thomson Reuters I/B/E/S.  Full Article

IDEXX Laboratories Inc reaffirms FY 2015 guidance
Thursday, 30 Jul 2015 07:00am EDT 

IDEXX Laboratories Inc:Reaffirms FY 2015 guidance adjusted to account for the June 15 two-for-one stock split.Expects FY 2015 revenue to be in the range of $1.600-$1.620.Expects FY 2015 EPS in the range of $2.07-$2.12.FY 2015 revenue of $1.603 billion and EPS of $2.09 - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Idexx Labs director End sells 5,000 shares of co's common stock on May 22

* Idexx Laboratories director William End reports sale of 5,000 shares of co's common stock on May 22 at average price of $162.55 per share - SEC filing Source text: http://bit.ly/2qSclJO Further company coverage: